Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles.

The differentiation of complete mole (CM), an aberrant androgenetic conceptus, from partial mole (PM) and hydropic abortion (HA) in early gestations is very important for patient management. In this study, 10 diploid voluntary artificial abortions (ABs), 20 diploid HAs, 20 triploid PMs, and 44 diploid CMs (including 4 persistent diseases), all of which were in the first trimester, were evaluated by immunohistochemistry of formalin-fixed tissues using a monoclonal antibody against p57(KIP2) protein (p57), a putative paternally imprinted inhibitor gene. DNA ploidy in all cases was analyzed by flow cytometry. In all ABs, nuclear p57 was strongly expressed in cytotrophoblasts, intermediate trophoblasts, villous stromal cells, and decidual stromal cells but was absent in syncytiotrophoblast. In diploid CMs, p57 expression in cytotrophoblasts and villous stromal cells was either absent (37 cases) or very low (7 cases). Villous intermediate trophoblasts stained for p57 in 12 cases of CM. On the other hand, 16 HAs and 19 PMs showed p57 levels comparable to those observed in ABs. Decidual stromal cells provided a reliable internal control in all cases. These findings support the hypothesis that misexpression of p57 is involved in the abnormal development of androgenetic CMs. This immunohistochemical analysis is a useful tool for the differential diagnosis of CMs.

[1]  S. Weremowicz,et al.  Discrimination of Complete Hydatidiform Mole From Its Mimics by Immunohistochemistry of the Paternally Imprinted Gene Product p57 KIP2 , 2001, The American journal of surgical pathology.

[2]  Young Tae Kim,et al.  Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases , 2000, Cancer.

[3]  M. Fukunaga.  Early partial hydatidiform mole: prevalence, histopathology, DNA ploidy, and persistence rate , 2000, Virchows Archiv.

[4]  H. Ropers,et al.  Human GRB10 is imprinted and expressed from the paternal and maternal allele in a highly tissue- and isoform-specific fashion. , 2000, Human molecular genetics.

[5]  T. Löning,et al.  Expression patterns of the cell-cycle inhibitor p27 and the cell-cycle promoter cyclin E in the human placenta throughout gestation: implications for the control of proliferation. , 1999, Placenta.

[6]  G. Mariuzzi,et al.  Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[7]  S. Elledge,et al.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.

[8]  G. Janossy,et al.  Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues. , 1997, Biochemical Society Transactions.

[9]  T. Hassold,et al.  Very early complete hydatidiform mole. , 1996, Human pathology.

[10]  A. Feinberg,et al.  Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Fukunaga,et al.  Incidence of hydatidiform mole in a Tokyo hospital: a 5-year (1989 to 1993) prospective, morphological, and flow cytometric study. , 1995, Human pathology.

[12]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[13]  M. Fukunaga.  Histopathologic study of partial hydatidiform moles and DNA triploid placentas , 1994, Pathology international.

[14]  M. Leader,et al.  Partial hydatidiform mole: a common but underdiagnosed condition. A 3-year retrospective clinicopathological and DNA flow cytometric analysis. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[15]  M. Fukunaga,et al.  Application of flow cytometry in diagnosis of hydatidiform moles. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[16]  R. Berkowitz,et al.  Natural History of Partial Molar Pregnancy , 1985, Obstetrics and gynecology.

[17]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  U. Surti,et al.  The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. , 1978, American journal of obstetrics and gynecology.

[19]  K. Ohama,et al.  Androgenetic origin of hydatidiform mole , 1977, Nature.